Freedom Investment Management’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-30,613
Closed -$428K 771
2022
Q2
$428K Buy
+30,613
New +$409K 0.05% 503
2020
Q3
Sell
-18,623
Closed -$269K 593
2020
Q2
$269K Sell
18,623
-530
-3% -$6.97K 0.03% 434
2020
Q1
$412K Buy
19,153
+189
+1% +$3.48K 0.04% 393
2019
Q4
$405K Sell
18,964
-310
-2% -$6.94K 0.04% 393
2019
Q3
$443K Sell
19,274
-2,683
-12% -$57.2K 0.04% 387
2019
Q2
$432K Sell
21,957
-2,170
-9% -$42.3K 0.04% 402
2019
Q1
$470K Sell
24,127
-777
-3% -$14.7K 0.04% 395
2018
Q4
$410K Sell
24,904
-1,352
-5% -$27.2K 0.03% 476
2018
Q3
$613K Buy
26,256
+1,305
+5% +$29.6K 0.04% 457
2018
Q2
$542K Buy
+24,951
New +$487K 0.03% 517
2014
Q1
Sell
-13,443
Closed -$351K 466
2013
Q4
$351K Buy
+13,443
New +$347K 0.09% 248

Other funds holding SBRA

Freedom Investment Management's SBRA Position: Q3 2022 in Review

Freedom Investment Management sold out of Sabra Healthcare REIT (SBRA) in Q3 2022, closing a stake of 30,613 shares — an estimated $428K sold.

Freedom Investment Management first reported a position in SBRA in Q4 2013 and held it in 11 quarters. The position peaked at $613K in Q3 2018. 332 funds tracked by Wall St. Rank hold SBRA as of Q3 2022.

  • Freedom Investment Management reported no remaining Sabra Healthcare REIT position as of Q3 2022 after selling out during the quarter.
  • Freedom Investment Management sold 30,613 Sabra Healthcare REIT shares in Q3 2022, an estimated $428K.
  • Freedom Investment Management first reported a position in Sabra Healthcare REIT in Q4 2013 and held it in 11 quarters.
  • Freedom Investment Management's Sabra Healthcare REIT position peaked at $613K in Q3 2018.
  • 332 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q3 2022.

Based on Freedom Investment Management's 13F filing for Q3 2022, filed 24 Oct 2022.